文献速递多重用药老年慢病共病管理

日本多重用药趋势:一项全国性回顾性研究

Trends in Polypharmacy in Japan: A Nationwide Retrospective Study.
PubMed 文献 · J Am Geriatr Soc · 2018-10-06

该研究基于2010至2016年日本医保理赔数据,分析20岁及以上人群多重用药趋势。结果显示,年龄标化多重用药月患病率从85.2/1000人升至93.8/1000人,过度多重用药从13.6升至14.0/1000人;2016年80岁及以上人群多重用药率最高(326.8/1000人)。总体趋势先升后降,2013年后有所回落。

要点

  • 2016年80岁及以上人群多重用药率最高,达326.8/1000人。
  • 年龄标化多重用药率从2010年85.2/1000人升至2016年93.8/1000人。
  • 多重用药年变化率2010–2012年增6.3%,2012–2016年降0.7%。

核心结论

  • 日本多重用药总体趋势在研究期间上升,但2013年后增长停止并出现下降。

主要发现

  • 年龄标化多重用药月患病率从2010年85.2/1000人升至2016年93.8/1000人。
  • 年龄标化过度多重用药月患病率从2010年13.6/1000人升至2016年14.0/1000人。
  • 2016年80岁及以上人群多重用药率最高(326.8/1000人),65至79岁人群次之(167.3/1000人)。
  • 多重用药率2010至2012年每年增加6.3%(95%CI=4.0-8.7),2012至2016年每年下降0.7%(95%CI=-1.3-0.0)。
  • 过度多重用药率2010至2013年每年增加4.5%(95%CI=1.1-8.0),2013至2016年每年下降3.7%(95%CI=-6.7至-0.6)。

关键数值与推荐

  • 多重用药定义为每月使用5种及以上口服处方药,过度多重用药定义为每月使用10种及以上口服处方药。

临床怎么用

  • 老年医学科应关注80岁及以上高龄人群的多重用药风险,结合年龄分层进行用药评估。
  • 政策变化可能影响多重用药趋势,临床用药管理可参考全国性趋势数据。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe and examine trends in polypharmacy according to age in Japan from 2010 to 2016. DESIGN: Retrospective observational study. SETTING: Outpatient settings. PARTICIPANTS: Japanese individuals aged 20 and older. MEASUREMENTS: We analyzed pharmacy claims data that the Japanese Ministry of Health, Labor, and Welfare provided in the Survey of Medical Care Activities in Public Health Insurance from 2010 to 2016. The use of 5 or more oral prescription medications per month was defined as polypharmacy and of 10 or more as excessive polypharmacy. Regression analysis was used to estimate trends in polypharmacy with annual percentage changes. Using number of medications (polypharmacy vs excessive polypharmacy), trends in polypharmacy and crude and age-adjusted rates of polypharmacy per 1,000 persons were calculated according to year and age group (20-34, 35-49, 50-64, 65-79, ≥ 80). RESULTS: We analyzed 240 million pharmacy claims data. The age-adjusted monthly prevalence rate of polypharmacy increased from 85.2 to 93.8 per 1,000 persons per month and of excessive polypharmacy from 13.6 to 14.0 per 1,000 persons per month from 2010 to 2016 in the entire study population. The highest rate of polypharmacy (per 1,000 persons) was observed in 2016 in those aged 80 and older (326.8), followed by those aged 65 to 79 (167.3). The polypharmacy rate increased by 6.3% (95% confidence interval (CI)=4.0-8.7) per year from 2010 to 2012, then decreased by 0.7% (95% CI=-1.3-0.0) per year from 2012 to 2016. The rate of excessive polypharmacy increased by 4.5% (95% CI=1.1-8.0) per year from 2010 to 2013 and then decreased by 3.7% (95% CI=-6.7 to -0.6) per year from 2013 to 2016. CONCLUSION: The overall trend of polypharmacy in Japan increased during the study period, although the increase ceased in 2013 and then declined from 2013 to 2016. Policy changes in Japan might be responsible for some of the changes. J Am Geriatr Soc 66:2267-2273, 2018.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Onoue H, Koyama T, Zamami Y, et al. Trends in Polypharmacy in Japan: A Nationwide Retrospective Study. J Am Geriatr Soc. 2018. PMID: 30291747. doi:10.1111/jgs.15569

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。